XML 45 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Shareholders' Equity (Tables)
12 Months Ended
Dec. 31, 2022
Stockholders' Equity Note [Abstract]  
Schedule of option activity for options to employees, officers and directors
  

For the year ended December 31,

 
   2022   2021   2020 
   Amount of options   Weighted average exercise price   Weighted average remaining contractual life   Amount of options   Weighted average exercise price   Weighted average remaining contractual life   Amount of options   Weighted average exercise price   Weighted average remaining contractual life 
       $           $           $     
Outstanding as of beginning of period   1,264,868    6.14(*)   7.5    1,639,792    6.14    8.9    706,728    6.14    4.9 
Granted   1,058,890    1.85                      1,502,248    6.14      
Exercised   (1,672)   6.14         (20,724)   6.14         
    
           
Forfeited or expired   (421,190)   6.14         (354,200)   6.14         (569,184)   6.14      
                                              
Outstanding as of end of period   1,900,896    2.20    8.2    1,264,868    6.14    7.5    1,639,792    6.14    6.5 
Exercisable as of end of period   805,062    2.46    6.6    683,723    6.14    7.4    595,980    6.14    6.8 

 

(*)Regarding repricing during 2022, see Note 8E(3)(k) below.

 

Schedule of total share-based payment expense related to options granted to employees
   Year ended December 31, 
   2022   2021   2020 
             
Cost of revenues  $8   $36   $
 
Research and development   174    608    1,119 
General and administrative   323    411    1,162 
Total share-based payment expense  $505   $1,055   $2,281